Martín-Asenjo, Roberto
Gregson, John
Rossello, Xavier http://orcid.org/0000-0001-6783-8463
Van de Werf, Frans
Medina, Jesús
Danchin, Nicolas
Pocock, Stuart
Bueno, Héctor
Funding for this research was provided by:
AstraZeneca Schweiz (N/A)
Article History
Received: 20 May 2020
Accepted: 16 December 2020
First Online: 8 January 2021
Compliance with Ethical Standards
:
: No animal studies were carried out by the authors for this article. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: RMA has received consulting fees from AstraZeneca and Bayer, and speaking fees or support for attending scientific meetings from Daichii-Sankyo, Bayer, and Cardiome. JG has received grants from AstraZeneca during the conduct of the study and outside of the submitted work. XR has nothing to disclose. FVdW has received consulting fees and research grants from Boehringer Ingelheim and Merck, and consulting fees from Roche, Sanofi Aventis, AstraZeneca, and The Medicines Company. JM is an employee of AstraZeneca. ND has received consulting or speaking fees from Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, GlaxoSmithKline, Intercept, MSD, Novartis, Novo-Nordisk, Pfizer, Sanofi, and Servier. SP has received research grant support from AstraZeneca. HB has received research funding from the Instituto de Salud Carlos III (PIE16/00021), AstraZeneca, BMS, Janssen, and Novartis; consulting fees from Abbott, AstraZeneca, Bayer, BMS-Pfizer, and Novartis; and speaking fees or support for attending scientific meetings from AstraZeneca, Bayer, BMS-Pfizer, Ferrer, Novartis, Servier, and MEDSCAPE-the ExternalRef removed.